Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genesDarren Hodgson, J. Carl Barrett, Lynda Grinsted et al.|British Journal of Cancer|2018Cited by 233
Abstract 2398: Activity of the PARP inhibitor olaparib in ATM-deficient gastric cancer: from preclinical models to the clinicDarren Hodgson, Mark J. O’Connor, Helen Mason et al.|Cancer Research|2014Cited by 7